Direct-Acting Antivirals (DAAs): Drug-Drug Interactions (DDIs) in the Treatment of Hepatitis C Virus (HCV)-Reference-Cited by-同舟云学术

Direct-Acting Antivirals (DAAs): Drug-Drug Interactions (DDIs) in the Treatment of Hepatitis C Virus (HCV)

Published:2017-10-04 Issue: Volume: Page:
ISSN:
Container-title:Update on Hepatitis C
language:
Short-container-title:

Author:

Steiner Sabina,Raguž-Lučić Nikola,Erceg Damir

Publisher

InTech

Link

http://www.intechopen.com/download/pdf/56976

Reference27 articles.

1. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clinical Microbiology and Infection. 2011;17:107-115

2. European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2016. Journal of Hepatology. 2017;66(1):153-167

3. Webster DP, Klenerman P, Dusheiko GM. Hepatitis C. Lancet 2015;385:1124-1135

4. WHO. Guidelines for the screening care and treatment of persons with chronic hepatitis C infection. Updated version, April 2016. World Health Organisation. http://www.who.int/hepatitis/publications/hepatitis-c-guidelines-2016/en/ (Accessed on May 02, 2017)

5. Kelleher TB. Management of the side effects of peginterferon and ribavirin used for treatment of chronic hepatitis C virus infection. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc http://www.uptodate.com (Accessed on February 02, 2017.)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2023-10-09

2. Comorbidities and the use of comedications among patients with chronic hepatitis C in Korea: A nationwide cross-sectional study;The Korean Journal of Internal Medicine;2023-05-01

3. Special Considerations in the Management of HIV and Viral Hepatitis Coinfections in Liver Transplantation;Hepatic Medicine: Evidence and Research;2022-04

4. Safety Profile of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Hepatitis C in Romania: an Analysis Conducted in VigiBase®/ WHO;Journal of Gastrointestinal and Liver Diseases;2020-10-27

5. A Pharmacology Perspective on Simultaneous Tuberculosis and Hepatitis C Treatment;Antimicrobial Agents and Chemotherapy;2019-12